These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18159774)

  • 41. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surge in treatment admissions related to methamphetamine use in Cape Town, South Africa: implications for public health.
    Plüddemann A; Myers BJ; Parry CD
    Drug Alcohol Rev; 2008 Mar; 27(2):185-9. PubMed ID: 18264880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methamphetamine use among Australian workers and its implications for prevention.
    Roche AM; Pidd K; Bywood P; Freeman T
    Drug Alcohol Rev; 2008 May; 27(3):334-41. PubMed ID: 18368616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rise of methamphetamine in Southeast and East Asia.
    McKetin R; Kozel N; Douglas J; Ali R; Vicknasingam B; Lund J; Li JH
    Drug Alcohol Rev; 2008 May; 27(3):220-8. PubMed ID: 18368602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation.
    Borders TF; Booth BM; Han X; Wright P; Leukefeld C; Falck RS; Carlson RG
    Addiction; 2008 May; 103(5):800-8. PubMed ID: 18412758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV needle risk behaviors and drug use: a comparison of crack-smoking and nonsmoking injection drug users in Ohio.
    Carlson RG; Falck RS; Wang J; Siegal HA; Rahman A
    J Psychoactive Drugs; 1999; 31(3):291-7. PubMed ID: 10533976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
    Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
    Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methamphetamine--what primary care practitioners need to know.
    McAvoy BR
    J Prim Health Care; 2009 Sep; 1(3):170-6. PubMed ID: 20690379
    [No Abstract]   [Full Text] [Related]  

  • 49. Essential/precursor chemicals and drug consumption: impacts of US sodium permanganate and Mexico pseudoephedrine controls on the numbers of US cocaine and methamphetamine users.
    Cunningham JK; Liu LM; Callaghan RC
    Addiction; 2016 Nov; 111(11):1999-2009. PubMed ID: 27529812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
    McKetin R; Kelly E
    Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired physical health among methamphetamine users in comparison with the general population: the role of methamphetamine dependence and opioid use.
    McKetin R; Kelly E; McLaren J; Proudfoot H
    Drug Alcohol Rev; 2008 Sep; 27(5):482-9. PubMed ID: 18608459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.
    Sliman S; Waalen J; Shaw D
    Cardiovasc Toxicol; 2016 Oct; 16(4):381-9. PubMed ID: 26661075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methamphetamine abuse and dentistry.
    Hamamoto DT; Rhodus NL
    Oral Dis; 2009 Jan; 15(1):27-37. PubMed ID: 18992021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.
    Shoptaw S; Peck J; Reback CJ; Rotheram-Fuller E
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():161-8. PubMed ID: 12825759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrocardiographic abnormalities in methamphetamine abusers.
    Haning W; Goebert D
    Addiction; 2007 Apr; 102 Suppl 1():70-5. PubMed ID: 17493055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An ethnographic exploration of self-reported violence among rural methamphetamine users.
    Sexton RL; Carlson RG; Leukefeld CG; Booth BM
    J Ethn Subst Abuse; 2009; 8(1):35-53. PubMed ID: 19266373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute coronary syndrome and crystal methamphetamine use: a case series.
    Wijetunga M; Bhan R; Lindsay J; Karch S
    Hawaii Med J; 2004 Jan; 63(1):8-13, 25. PubMed ID: 15011896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methamphetamine abuse: medical and dental considerations.
    Smart RJ; Rosenberg M
    J Mass Dent Soc; 2005; 54(2):44-6, 48-9. PubMed ID: 16149403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Consumption of New Psychoactive Substances and Methamphetamine.
    de Matos EG; Hannemann TV; Atzendorf J; Kraus L; Piontek D
    Dtsch Arztebl Int; 2018 Jan; 115(4):49-55. PubMed ID: 29467073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.